SHINE Technologies' FDA filing for radioisotope clears way for commercial use
July 29, 2022 at 10:03 AM EDT
Janesville's SHINE Technologies said Friday that the company had submitted a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for a radioisotope used in cancer treatment.
